Drug recalls declined more than 25 percent in the second quarter of 2018, compared to the first quarter of the year, according to Stericycle Expert Solutions' latest report on U.S. product recalls released Aug. 8.
Pharmacy
Health systems will see a 4.92 percent price increase for drug purchases in 2019, according to estimates from Vizient's July 2018 Drug Price Forecast report.
In a move expected to save $3.2 billion, Express Scripts Holding will drop 48 drugs from its lineup of covered therapies in 2019, reports Bloomberg.
President Donald Trump said his administration will make an announcement next week about dropping prescription drug prices "really substantially," according to Reuters.
Despite strong growth in its retail pharmacy business, CVS Health ended the second quarter with a $2.56 billion loss, according to a recently released earnings report.
Advertisement
CMS will give private Medicare Advantage plans more negotiating power over prices for Part B drugs, which are administered in physician offices and hospitals, in an effort to reduce spending, according to an Aug. 7 news release.
People care about big pharma's actions — especially as the industry faces heightened political pressure to lower prescription drug prices and intensified scrutiny about pricing strategies. While the public knows many of the top dogs by name, there are other…
Several major pharmaceutical companies recently shut down their antibiotic and antiviral research projects, backing away from the growing threat of superbugs, which may kill more than 10 million people a year by 2050.
Sun Pharmaceutical Industries issued a recall of 5,215 units of testosterone cypionate injections in the U.S., according to the Economic Times.
Canonsburg, Pa.-based Mylan argues the U.S. is wasting billions of dollars on name brand anti-HIV drugs, instead of making generic alternatives, according to Science.